What Does the ENDURANCE Trial Mean for Myeloma Patients?

In this segment from our recent Answers Now Program, patient advocate Jim Omel explains what the ENDURANCE trial is and shares the latest results. He and host Jack Aiello discuss side effects, pros and cons, and what it all means for their fellow myeloma patients. This trial was recently presented at the 2020 American Society of Clinical Oncology (ASCO) annual meeting. Watch now to learn more.

This is the first part of a five-part series. Watch Part 2 at CAR T-Cell Clinical Trial Updates for Myeloma Patients, Part 3 at What Does the StaMINA Trial Mean for Myeloma Patients? ,Part 4 at Treating Myeloma in Patients with Renal Insufficiency, and Part 5 at New Treatment Options Give Hope to Myeloma Patients .

This article was originally published June 12, 2020 and most recently updated June 18, 2020.
© 2024 HealthCentral LLC. All rights reserved.

More on Multiple Myeloma